ApconiX is delighted to welcome Dr Sean Hammond who joins us as a Principal Scientist in Immunotoxicology/Immune-oncology and is the latest addition to our growing target safety assessment team. Sean recently completed his PhD at the University of Liverpool, following on from his first degree in Pharmacology where he received the year prize. His degree [...]
ApconiX is delighted to welcome Dr James Sidaway who joins us as Target Safety Assessment (TSA) Discipline Lead. The target safety assessment team is growing as the demand for our service continues to increase significantly. James (also known as Sid) is an experienced and innovative toxicologist having worked for over 20 years in the pharmaceutical [...]
ApconiX is a team of world-renowned nonclinical safety experts with over 400 years of drug discovery and development expertise. We were formed in 2015 by three scientists with the drive and ambition to create a world-renowned company. We are now looking to grow our team of experts by the addition of talented and dedicated life scientists [...]
ApconiX Welcomes Simon Craige to the Team ApconiX is delighted to welcome Simon Craige to the team. Simon has over 15 years’ nonclinical and toxicology experience working in several medical and pharmaceutical organisations across multiple disciplines including small molecules, vaccines, biologics, and medical devices. He has experience of a [...]
ApconiX is delighted to welcome Dr Duncan Armstrong to the team. Duncan has expert knowledge in molecular pharmacology, preclinical safety pharmacology and secondary pharmacodynamics gained over 18 years working in drug discovery and development at AstraZeneca UK and Novartis USA. He has worked with project teams across multiple therapy areas and at all stages of [...]
We are recruiting an Admin & Finance Assistant (initially part time with flexible working options).ApconiX is a team of world-renowned nonclinical safety experts with over 400 years of drug discovery and development expertise. We were formed in 2015 by three scientists with the drive and ambition to create a unique company. We are [...]
ApconiX is a team of world-renowned nonclinical safety experts with over 400 years of drug discovery and development expertise. We were formed in 2015 by three scientists with the drive and ambition to create a world-renowned company. We are now looking to grow our team of experts by the addition of talented and dedicated life [...]
ApconiX is delighted to welcome Dr Laurence Bishop to the team as our Head of Business Development. Laurence is an experienced DMPK and toxicological scientist with 20 years’ experience of nonclinical drug development. Specialising in business development for the past 13 years, we are looking forward to Laurence playing a key role in our growth [...]
ApconiX welcomes Dr Selvan Bavan, who joins us to carry out ion channel research using manual patch-clamp while learning more about using automated patch-clamp by working with Dr Michael Morton and Dr Karen Jones. Selvan commented, “Conventional manual patch-clamp is regarded as a ‘gold standard’ technique to record ion channel currents, but this technique has [...]
ApconiX welcomes Charlotte North to the team. Charlotte graduated from Sheffield University in July with a degree in Biomedical Sciences and is working in the ApconiX Ion Channel Laboratory as an industry placement student this month. Charlotte has been spending her time, since graduating, exploring the many opportunities the pharmaceutical industry can offer. She is [...]
